glp 1 meds while breastfeeding on GLP-1: Safety & Clinical Considerations – PlexusDx Ozempic® or Mounjaro® and Breastfeeding:

Descriptions and sources of reagents and detailed methods of our mouse models of experimental MI in vivo (66), IRI in vivo (67), IRI ex vivo (4, 21), as well as mouse and human cellular injury models in vitro (21, 68) are provided in the Supplemental Methods

Some analysts believe the global GLP-1 market could exceed $100 billion annually within the next decade

Note: Compounded Semaglutide and Tirzepatide are only provided pursuant to a valid prescription for each individual patient after evaluation by a trained medical professional

Drug Safety Update

The standard protocol starts tirzepatide at 2.5 mg regardless of prior semaglutide dose